
The Centre of Scientific & Industrial Research (CSIR) and Bengal government’s randomized control trial on use of convalescent plasma therapy in severe Covid-19 patients has shown an immediate reduction in hypoxia (oxygen deprivation) as compared to patients on standard therapy. The findings also indicate an anti-inflammatory role of the therapy.
from https://ift.tt/3mQGiGM
via
IFTTT
Comments
Post a Comment